Search Results - "Salsali, Afshin" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Vyzkoušejte nový nástroj s podporou AI Summon Research Assistant BETA

Cover Image

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

by Voors, Adriaan A., Angermann, Christiane E., Teerlink, John R., Collins, Sean P., Kosiborod, Mikhail, Biegus, Jan, Ferreira, João Pedro, Nassif, Michael E., Psotka, Mitchell A., Tromp, Jasper, Borleffs, C. Jan Willem, Ma, Changsheng, Comin-Colet, Joseph, Fu, Michael, Janssens, Stefan P., Kiss, Robert G., Mentz, Robert J., Sakata, Yasushi, Schirmer, Henrik, Schou, Morten, Schulze, P. Christian, Spinarova, Lenka, Volterrani, Maurizio, Wranicz, Jerzy K., Zeymer, Uwe, Zieroth, Shelley, Brueckmann, Martina, Blatchford, Jonathan P., Salsali, Afshin, Ponikowski, Piotr
Published in Nature Medicine (01.03.2022)

Get full text

Journal Article Magazine Article

Cover Image

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

by Biegus, Jan, Voors, Adriaan A, Collins, Sean P, Kosiborod, Mikhail N, Teerlink, John R, Angermann, Christiane E, Tromp, Jasper, Ferreira, Joao Pedro, Nassif, Michael E, Psotka, Mitchell A, Brueckmann, Martina, Salsali, Afshin, Blatchford, Jonathan P, Ponikowski, Piotr
Published in European heart journal (01.01.2023)

Get full text

Journal Article

Cover Image

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes

by Kohler, Sven, Salsali, Afshin, Hantel, Stefan, Kaspers, Stefan, Woerle, Hans J., Kim, Gabriel, Broedl, Uli C.
Published in Clinical therapeutics (01.06.2016)

Get full text

Journal Article

Cover Image

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes

by Pratley, Richard E., Salsali, Afshin
Published in Current medical research and opinion (01.04.2007)

Get full text

Journal Article

Cover Image

Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA‐REG OUTCOME trial

by Fitchett, David, Inzucchi, Silvio E., Zinman, Bernard, Wanner, Christoph, Schumacher, Martin, Schmoor, Claudia, Ohneberg, Kristin, Ofstad, Anne Pernille, Salsali, Afshin, George, Jyothis T., Hantel, Stefan, Bluhmki, Erich, Lachin, John M., Zannad, Faiez
Published in ESC Heart Failure (01.12.2021)

Get full text

Journal Article

Cover Image

Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus

by Kovacs, Christopher S., Seshiah, Veeraswamy, Merker, Ludwig, Christiansen, Anita Vedel, Roux, Flavien, Salsali, Afshin, Kim, Gabriel, Stella, Peter, Woerle, Hans-Juergen, Broedl, Uli C.
Published in Clinical therapeutics (01.08.2015)

Get full text

Journal Article

Cover Image

Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers

by Macha, Sreeraj, Koenen, Rüdiger, Sennewald, Regina, Schöne, Katja, Hummel, Noemi, Riedmaier, Stephan, Woerle, Hans J., Salsali, Afshin, Broedl, Uli C.
Published in Clinical therapeutics (01.02.2014)

Get full text

Journal Article

Cover Image

Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension

by Tikkanen, Ilkka, Narko, Kirsi, Zeller, Cordula, Green, Alexandra, Salsali, Afshin, Broedl, Uli C., Woerle, Hans J.
Published in Diabetes care (01.03.2015)

Get full text

Journal Article

Cover Image

Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy

by Rosenstock, Julio, Vico, Marisa, Wei, Li, Salsali, Afshin, List, James F.
Published in Diabetes care (01.07.2012)

Get full text

Journal Article

Cover Image

Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes

by Rosenstock, Julio, Jelaska, Ante, Frappin, Guillaume, Salsali, Afshin, Kim, Gabriel, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes care (01.07.2014)

Get full text

Journal Article

Cover Image

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

by Doehner, Wolfram, Anker, Stefan D, Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Ferreira, João Pedro, Salsali, Afshin, Kaempfer, Carolyn, Brueckmann, Martina, Pocock, Stuart J, Januzzi, James L, Packer, Milton
Published in European heart journal (21.09.2022)

Get full text

Journal Article

Cover Image

Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension

by Ferdinand, Keith C., Izzo, Joseph L., Lee, Jisoo, Meng, Leslie, George, Jyothis, Salsali, Afshin, Seman, Leo
Published in Circulation (New York, N.Y.) (30.04.2019)

Get full text

Journal Article

Cover Image

Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride

by Kohler, Sven, Kaspers, Stefan, Salsali, Afshin, Zeller, Cordula, Woerle, Hans J.
Published in Diabetes care (01.08.2018)

Get full text

Journal Article

Cover Image

Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial

by FERRANNINI, Ele, WEIHUA TANG, JIMENEZ RAMOS, Silvia, LIST, James F, SALSALI, Afshin
Published in Diabetes care (01.10.2010)

Get full text

Journal Article

Cover Image

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

by Abraham, William T, Lindenfeld, JoAnn, Ponikowski, Piotr, Agostoni, Piergiuseppe, Butler, Javed, Desai, Akshay S, Filippatos, Gerasimos, Gniot, Jacek, Fu, Michael, Gullestad, Lars, Howlett, Jonathan G, Nicholls, Stephen J, Redon, Josep, Schenkenberger, Isabelle, Silva-Cardoso, José, Störk, Stefan, Krzysztof Wranicz, Jerzy, Savarese, Gianluigi, Brueckmann, Martina, Jamal, Waheed, Nordaby, Matias, Peil, Barbara, Ritter, Ivana, Ustyugova, Anastasia, Zeller, Cordula, Salsali, Afshin, Anker, Stefan D
Published in European heart journal (11.02.2021)

Get full text

Journal Article

Cover Image

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced

by Ferreira, João Pedro, Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos, Iwata, Tomoko, Salsali, Afshin, Zeller, Cordula, Pocock, Stuart J., Zannad, Faiez, Packer, Milton
Published in European journal of heart failure (01.04.2022)

Get full text

Journal Article

Cover Image

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

by Kosiborod, Mikhail N., Angermann, Christiane E., Collins, Sean P., Teerlink, John R., Ponikowski, Piotr, Biegus, Jan, Comin-Colet, Josep, Ferreira, João Pedro, Mentz, Robert J., Nassif, Michael E., Psotka, Mitchell A., Tromp, Jasper, Brueckmann, Martina, Blatchford, Jonathan P., Salsali, Afshin, Voors, Adriaan A.
Published in Circulation (New York, N.Y.) (26.07.2022)

Get full text

Journal Article

Cover Image

Empagliflozin compared with glimepiride in metformin‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial

by Ridderstråle, Martin, Rosenstock, Julio, Andersen, Knut R., Woerle, Hans J., Salsali, Afshin
Published in Diabetes, obesity & metabolism (01.12.2018)

Get full text

Journal Article

Cover Image

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial

by Tromp, Jasper, Ponikowski, Piotr, Salsali, Afshin, Angermann, Christiane E., Biegus, Jan, Blatchford, Jon, Collins, Sean P., Ferreira, João Pedro, Grauer, Claudia, Kosiborod, Mikhail, Nassif, Michael E., Psotka, Mitchell A., Brueckmann, Martina, Teerlink, John R., Voors, Adriaan A.
Published in European journal of heart failure (01.05.2021)

Get full text

Journal Article

Cover Image

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME ® trial

by Fitchett, David, Zinman, Bernard, Wanner, Christoph, Lachin, John M., Hantel, Stefan, Salsali, Afshin, Johansen, Odd Erik, Woerle, Hans J., Broedl, Uli C., Inzucchi, Silvio E.
Published in European heart journal (14.05.2016)

Get full text

Journal Article

1
2
3
4
5
6
7
8
Next
[8]